Vesam AB Competitors

Oracle is a global leader in AI, delivering the cloud infrastructure, data, and applications that organizations across the world trust to successfully achieve business outcomes at scale. Oracle Cloud Infrastructure (OCI) provides fast, flexible, scalable AI infrastructure. With superior compute performance and network design, a comprehensive choice of AI services for developing and orchestrating agentic AI workflows at scale, and unrivaled data control, security, privacy, and governance, OCI is designed for AI workloads. It also gives customers the flexibility to run their workloads wherever they need by supporting public cloud, multicloud, hybrid cloud, sovereign, and on-premises deployments. The Oracle AI Database is the only database with AI natively built in everywhere. By bringing AI to where data lives, the Oracle AI Database delivers enterprise-grade AI securely, cost-effectively, and at scale. In-database machine learning and vector search enable AI models to run where data resides. Support for multi-modal data (structured, unstructured, graph, vector) enables richer AI use cases. The Oracle AI Data Platform enables organizations to build, deploy, and govern AI agents and applications on top of private, secure, and distributed enterprise data. This enables organizations to operationalize AI without compromising data security or control. Oracle Applications embed AI directly into business workflows and industry processes to ensure AI is delivered in context, where work happens. They include the only applications suite that brings AI to every aspect of a business, with AI-powered ERP, HCM, and CX applications, and the Oracle Health Suite which provides applications for managing the entire healthcare ecosystem. Oracle also provides industry-specific cloud application suites for more than two dozen industries and NetSuite, the world’s first cloud computing company. This LinkedIn page serves as Oracle’s official global company page.

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical andConsulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 22,000+ global employees work in partnership with biopharmaceutical leaders, emerging innovators and sites todesign and deliver clinical trials with patients in mind — broadening access and making clinicalresearch a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’smost complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven deliveryand trustedexecution are accelerating the delivery of life-changingtreatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and2023 Society for Clinical Research Sites Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove any comments that do not adhere to our guidelines as well as report users who violate the rules of our page.

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 6,300 people across 46 countries.